Hypermethylation of p15/ink4b/MTS2 gene is differentially implicated among non-Hodgkin's lymphomas

Leukemia

Volumn 12, Issue 6, 1998, Pages 937-941

  Martinez Delgado, B ^a   Robledo, M ^a   Arranz, E ^a   Osorio, A ^a   Garcia M J ^a   Echezarreta, G ^a   Rivas, C ^a   Benitez, J ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Hypermethylation; Non Hodgkin's lymphomas; p15 gene; PCR; Restriction enzymes; Southern blot

Indexed keywords

DNA; RESTRICTION ENDONUCLEASE;

ARTICLE; BURKITT LYMPHOMA; CONTROLLED STUDY; DNA METHYLATION; EXON; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SOUTHERN BLOTTING; T CELL LYMPHOMA; TUMOR SUPPRESSOR GENE;

EID: 0031804887     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401009     Document Type: Article

References (14)

1. Kamb A, Gruis N, Weaver-Fendhaus J, Liu Q, Harsman K, Tavtigian SV, Stocken E, Day RS III, Johnson BE, Skolnick MH. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440.
2. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994; 368: 753-756.
3. Jen J, Harper W, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Wilson JKV, Kinzler KW, Vogelstein B. Deletions of p16 and p15 genes in brain tumors. Cancer Res 1994; 54: 6353-6358.
4. Hannon GJ, Beach D. P15ink4b is a potential effector of TGF-B induced cell cycle arrest. Nature 1994; 371: 257-261.
5. Hebert J, Cayuela JM, Barkeley J, Sigaux F. Candidate tumor suppressor genes MTS2 (p16ink4A) and MTS2 (p15ink4B) display frequent homozygous deletions in primary cells from T but not from B-cell lineage acute lymphoblastic leukemias. Blood 1994; 84: 4038-4044.
6. Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee WC, Altomare DA, Nobori T, Olopade OL, Buckler AJ, Testa JR. P16 alterations and deletions mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 1994; 54: 5547-5551.
7. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 1995; 55: 20-23.
8. Ohnishi H, Hanada R, Horibe K, Hongo T, Kawamura M, Naritaka S, Bessho F, Yanagisavva M, Nobori T, Yamamori S, Hayashi Y. Homozogous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood. Leukemia 1996; 10: 1104-1110.
9. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC. Germline p16 mutations in familial melanoma. Nat Genet 1994; 8: 15-21.
10. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 1994; 8: 27-32.
11. Okamoto A, Hussian SP, Hagiwara K, Soillare EA, Rusin MR, Demetrick DJ, Serrano M, Hannon GJ, Shiseki M, Zariwala M, Xoing Y, Beach D, Yokota J, Harris CC. Mutations in the p16ink4A/MTS1/CDKN2, p15ink4B/MTS2 and p18 genes in primary and metastatic lung cancer. Cancer Res 1995; 55: 1448-1451.
12. Spruck CH III, Gonzalez-Zulueta M, Shibata A, Simoneau AR, Lin M, Gonzales F, Tsai YC, Jones PA. P16 gene in uncultured tumors. Nature 1994; 370: 183-184.
13. Merlo A, Herman JG, Mao L, Dee DJ, Gabrielson E, Burger P, Baylin SB, Sidransky D. 5′CpG island methylation is associated with transcriptional silencing of the tumor suppressor P16/CDKN2/MTS1 in human cancers. Nature Med 1995; 1: 686-692.
14. Otterson GA, Khleif SN, Chen W, Coxon AB, Kaye FJ. CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16ink4 induction by 5-aza 2′ deoxycytidine. Oncogene 1995; 11: 1211-1216.